Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

1997-08-14

Original market date: See footnote 1

1987-12-31

Product name:

MTE 4 INJ

DIN:

01945319 Electronic product monograph is not available

Company:

LYPHOMED, DIVISION OF FUJISAWA CANADA INC.
800 625 Cochrane Drive
Markham
Ontario
Canada L3R 9R9

Class:

Human

Dosage form(s):

Liquid

Route(s) of administration:

Intravenous

Number of active ingredient(s):

4

Schedule(s):

Ethical

 

American Hospital Formulary Service (AHFS): See footnote 3

88:29.00* See footnote6 

Anatomical Therapeutic Chemical (ATC): See footnote 4

B05XA30 COMBINATIONS OF ELECTROLYTES

Active ingredient group (AIG) number:See footnote5

0414689003

List of active ingredient(s)
Active ingredient(s) Strength
CHROMIUM (CHROMIUM SULFATE) 4 MCG / ML
COPPER (CUPRIC SULFATE) .4 MG / ML
MANGANESE (MANGANESE SULFATE) .1 MG / ML
ZINC (ZINC SULFATE) 1 MG / ML
Version 4.0.2
Date modified: